Given the inverse relationship in the distributions of FXR and PD-L1 in patients with NSCLC, there has been an increasing interest to explore whether FXR correlates with HVEM expression in NSCLC samples. This evidence concerns the gene NR1H4 and non-small cell lung carcinoma.